Vulnerability Assessment and Enhanced Community-based Care and Management of Patients With Tuberculosis in Korea: A Crossover Design
Journal of Preventive Medicine and Public Health · 2025
DOI: 10.3961/jpmph.24.597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Preventive Medicine and Public Health, 2025. Verfasst von Jeongmi Seo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Team II, Research and Developement Center, The Korean Institute of Tuberculosis, Korean National Tuberculosis Association, Cheongju, Korea. Hauptthemen laut MEDLINE: Tuberculosis, Community Health Services. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Disease Control and Prevention Agency, National Research Foundation of Korea, Ministry of Science and ICT.
Abstract (Originalsprache)
Objectives
People-centered care and social protection are critical for improving tuberculosis (TB) treatment outcomes. This study aimed to evaluate whether a vulnerability assessment tool, developed for an enhanced community-based care and management (ECCM) program in 2 Korean cities, could predict and improve final TB treatment outcomes based on patients’ vulnerability levels.
Methods
Treatment outcomes in the ECCM group were compared with those in a control group, stratified by vulnerability level. During stage 1, one city served as the intervention region and the other as the control, with a crossover in stage 2. The vulnerability assessment included all notified patients with TB, and those identified as highly vulnerable in the intervention group received social support following a consultation with a case manager.
Results
The vulnerability assessment tool demonstrated moderate predictive ability for unfavorable outcomes, with an area under the curve of 0.70 (95% confidence interval, 0.63 to 0.77). The patients with high vulnerability who received ECCM treatment demonstrated a 19.8-percentage point (%p) higher treatment success rate than the high vulnerability subcategory of the control group. ECCM also appeared to reduce loss to follow-up and TB-related mortality by 8.4%p and 7.3%p, respectively, although these findings should be interpreted with caution.
Conclusions
The results suggest that providing social support tailored to patient vulnerability at the time of diagnosis could improve TB treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Team II, Research and Developement Center, The Korean Institute of Tuberculosis, Korean National Tuberculosis Association, Cheongju, Korea.
- Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
- Division of Tuberculosis Prevention and Control, Bureau of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Korea.
- Division of Health Policy and Management, Korea University College of Health Science, Seoul, Korea.
Förderung
- Korea Disease Control and Prevention Agency
- National Research Foundation of Korea
- Ministry of Science and ICT
- Korea University
Zitieren
APA
Seo, J., Jeong, D., Lee, I. H., Han, J., Kwon, Y., Shim, E., & Choi, H. (2025). Vulnerability Assessment and Enhanced Community-based Care and Management of Patients With Tuberculosis in Korea: A Crossover Design. Journal of Preventive Medicine and Public Health. https://doi.org/10.3961/jpmph.24.597
Vancouver
Seo J, Jeong D, Lee IH, Han J, Kwon Y, Shim E, et al. Vulnerability Assessment and Enhanced Community-based Care and Management of Patients With Tuberculosis in Korea: A Crossover Design. Journal of Preventive Medicine and Public Health. 2025. doi:10.3961/jpmph.24.597
BibTeX
@article{Seo2025,
author = {Seo, Jeongmi and Jeong, Dawoon and Lee, In-Hyuk and Han, Jiyeon and Kwon, Yunhyung and Shim, Eunhye and Choi, Hongjo},
title = {Vulnerability Assessment and Enhanced Community-based Care and Management of Patients With Tuberculosis in Korea: A Crossover Design},
journal = {Journal of Preventive Medicine and Public Health},
year = {2025},
doi = {10.3961/jpmph.24.597}
}
EUVIMED